NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹209 Cr | ₹45 Cr | ₹46 Cr | ₹41 Cr | ₹20 Cr |
What is the latest Capital Work in Progress ratio of NEULAND LABORATORIES ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹209 Cr |
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹46 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹20 Cr |
How is Capital Work in Progress of NEULAND LABORATORIES Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹209 Cr | 370.22 | |
| Mar2025 | ₹45 Cr | -2.92 | |
| Mar2024 | ₹46 Cr | 13.13 | |
| Mar2023 | ₹41 Cr | 98.30 | |
| Mar2022 | ₹20 Cr | - | |
Compare Capital Work in Progress of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹23,677.3 Cr | -1.5% | 7.5% | 23.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -1.5% |
7.5% |
23.5% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses